{"id":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","kind":"companies","code":"UB-C10168","name":"Lingchuangyigu","nameBasis":"transliterated","summary":"Neuromodulation and brain-computer interface medical device developer.","description":"Neuromodulation and brain-computer interface medical device developer.","country":"China","category":null,"originalName":"领创医谷","eventDate":null,"website":"https://www.leadinno.cn/","sourceUpdatedAt":"2026-10-14T00:00:00.000Z","englishUpdatedAt":"2026-10-15T20:33:16.975Z","reviewedAt":"2026-10-15T20:33:16.975Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"439fb513dfd716e2e80c7ec866d693644921bd7012e1e8738ba0621637a1598a","companyId":null,"foundedYear":2016,"logoUrl":null,"originalText":"神经调控及脑机接口医疗器械研发商","sources":[],"related":[{"id":"a7047b62-9c5d-48c4-8f2f-4174067bfddc","kind":"people","code":"UB-P2384","name":"Ding Shan","nameBasis":"transliterated","summary":"Co-founder and COO","description":"","country":null,"category":null,"originalName":"丁杉","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T20:00:16.146Z","englishUpdatedAt":"2026-10-15T18:37:42.248Z","reviewedAt":"2026-10-15T18:37:42.248Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0c343bdc9f91189bce66be467fcab52f8adba40ec0be7c3e07458f86979cbb54","companyId":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","foundedYear":null,"logoUrl":null,"path":"/people/ding-shan"},{"id":"6983ae65-3a78-4bc1-bbfa-badb63fd8480","kind":"people","code":"UB-P2380","name":"Fan Bifa","nameBasis":"transliterated","summary":"Academic leader in pain medicine in China and professor.","description":"Academic leader in pain medicine in China and professor.","country":null,"category":null,"originalName":"樊碧发","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T20:00:16.118Z","englishUpdatedAt":"2026-10-15T19:39:49.573Z","reviewedAt":"2026-10-15T19:39:49.573Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5e8699897e994dc370ec7ac5c975df49cf35ac1d95e3796462b6e6e49d307218","companyId":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","foundedYear":null,"logoUrl":null,"path":"/people/fan-bifa"},{"id":"4ceb7b59-489d-4e5e-bf34-a9f2dfcd0bc2","kind":"people","code":"UB-P2381","name":"Han Jisheng","nameBasis":"transliterated","summary":"Foundational figure in neuromodulation in China and an academician.","description":"Foundational figure in neuromodulation in China and an academician.","country":null,"category":null,"originalName":"韩济生","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T20:00:16.126Z","englishUpdatedAt":"2026-10-15T19:39:49.128Z","reviewedAt":"2026-10-15T19:39:49.128Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a1b7c810173f5fd94750d948c4e5e216399f797fe97fa45d4cece0114ad1a6d0","companyId":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","foundedYear":null,"logoUrl":null,"path":"/people/han-jisheng"},{"id":"88dfa41f-2ea9-48e1-88fb-37bf6b462413","kind":"news","code":"88dfa41f-2ea9-48e1-88fb-37bf6b462413","name":"Lingchuangyigu completes Series B+ financing","nameBasis":"translated-title","summary":"On 2026-02-07, according to Xiniu Data, Lingchuangyigu completed Series B+ financing for an undisclosed amount. Investors were Saiying Capital.","description":"","country":null,"category":null,"originalName":"领创医谷完成B+融资","eventDate":"2026-02-07T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T12:44:28.220Z","englishUpdatedAt":"2026-10-15T20:50:22.105Z","reviewedAt":"2026-10-15T20:50:22.105Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"424188213286cc90771bd9531ed49317ab52b7525004a5cacfde1f89d0a1cc47","companyId":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","foundedYear":null,"logoUrl":null,"path":"/news/88dfa41f-2ea9-48e1-88fb-37bf6b462413"},{"id":"72e2a0d3-024f-410d-b8bd-6a73f427e3b7","kind":"news","code":"72e2a0d3-024f-410d-b8bd-6a73f427e3b7","name":"Lingchuangyigu raises RMB 200 million in Series B+ financing","nameBasis":"translated-title","summary":"On 2026-06-18, according to Xiniu Data, Lingchuangyigu completed Series B+ financing, raising RMB 200 million. Investors were Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), Zhongjin Capital. The company is a developer of neuromodulation and brain-computer interface medical devices.","description":"","country":null,"category":null,"originalName":"领创医谷完成B+融资，金额2亿人民币","eventDate":"2026-06-18T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-16T19:44:30.210Z","englishUpdatedAt":"2026-10-18T08:52:13.878Z","reviewedAt":"2026-10-18T08:52:13.878Z","snapshotAt":"2026-10-18T08:51:49.337Z","sourceHash":"ece6c7f15792d8844e6414b67909eef697599ffa3b309b4dab68435460278bc2","companyId":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","foundedYear":null,"logoUrl":null,"path":"/news/72e2a0d3-024f-410d-b8bd-6a73f427e3b7"},{"id":"c8f6523a-e987-433c-a7ea-55ed1ffb1f65","kind":"people","code":"UB-P2378","name":"Xu Tianrui","nameBasis":"transliterated","summary":"Founder of Beijing Lingchuang Yigu Technology Development Co., Ltd., with more than a decade in neuromodulation and brain–computer interfaces. Starting with an innovative wireless implantable neural electrical stimulation platform, the company develops technologies for pain management and neuromodulation. It raised more than CNY 200 million in 2026.","description":"Founder of Beijing Lingchuang Yigu Technology Development Co., Ltd., with more than a decade in neuromodulation and brain–computer interfaces. Starting with an innovative wireless implantable neural electrical stimulation platform, the company develops technologies for pain management and neuromodulation. It raised more than CNY 200 million in 2026.","country":null,"category":null,"originalName":"徐天睿","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T20:00:16.107Z","englishUpdatedAt":"2026-10-15T23:20:32.984Z","reviewedAt":"2026-10-15T23:20:32.984Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8515ae6a7a9075c059a130fa020161af767f709670f9f7379b48bc77630a2666","companyId":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","foundedYear":null,"logoUrl":null,"path":"/people/xu-tianrui"},{"id":"2b96e881-405d-416d-9147-cc33cf34c278","kind":"institutions","code":"UB-I127","name":"Zhongjin Capital","nameBasis":"transliterated","summary":"CICC's private investment and fund management platform, conducting equity investment and fund businesses.","description":"CICC's private investment and fund management platform, conducting equity investment and fund businesses.","country":null,"category":null,"originalName":"中金资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.826Z","englishUpdatedAt":"2026-10-15T21:25:20.182Z","reviewedAt":"2026-10-15T21:25:20.182Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fabbaea80f7795008324786c63e60db88b8a5ae0ca832882248834eb6ca554da","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/zhongjin-capital"},{"id":"fabebceb-cbe4-49a8-839d-08f5ac0ff704","kind":"institutions","code":"UB-I8211","name":"苏州创景领航创业投资合伙企业（有限合伙）","nameBasis":"transliterated","summary":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","description":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","country":null,"category":null,"originalName":"苏州创景领航创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:22.102Z","englishUpdatedAt":"2026-10-16T01:39:38.828Z","reviewedAt":"2026-10-16T01:39:38.828Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"f61fcdff894085f0a7071248eba7b508779305b00dfe25528e5567c8a81eff76","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership)","path":"/institutions/suzhou-chuangjinglinghang-venture-capital-partnership-limited-partnership"},{"id":"b1bd9b1f-cf89-424f-87a8-67130db3f0f3","kind":"institutions","code":"UB-I5904","name":"赛盈资本","nameBasis":"transliterated","summary":"Saiying Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","description":"Saiying Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","country":null,"category":null,"originalName":"赛盈资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:21.716Z","englishUpdatedAt":"2026-10-15T21:21:01.761Z","reviewedAt":"2026-10-15T21:21:01.761Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3c88ffb5e63e684a25ab9ad63222e7a62274e6246539f05b52ed2f49ac7cd775","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Saiying Capital","path":"/institutions/saiying-capital"}],"finance":{"funding":{"metric":"funding","count":2,"latest":{"value":28571428,"text":"2亿人民币","date":"2026-06-18T00:00:00.000Z","round":"Series B+","estimate":"RMB 200M"},"years":[2026],"points":[{"year":2026,"date":"2026-06-18T00:00:00.000Z","round":"Series B+","value":28571428,"eventIds":["72e2a0d3-024f-410d-b8bd-6a73f427e3b7"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":1,"records":[{"id":"72e2a0d3-024f-410d-b8bd-6a73f427e3b7","date":"2026-06-18T00:00:00.000Z","round":"Series B+","amountText":"2亿人民币","estimateUsd":28571428,"estimateLabel":"RMB 200M","estimateNote":"≈ $28.6M","investors":"苏州创景领航创业投资合伙企业（有限合伙），中金资本","institutions":[{"id":"2b96e881-405d-416d-9147-cc33cf34c278","kind":"institutions","code":"UB-I127","name":"Zhongjin Capital","nameBasis":"transliterated","summary":"CICC's private investment and fund management platform, conducting equity investment and fund businesses.","description":"CICC's private investment and fund management platform, conducting equity investment and fund businesses.","country":null,"category":null,"originalName":"中金资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.826Z","englishUpdatedAt":"2026-10-15T21:25:20.182Z","reviewedAt":"2026-10-15T21:25:20.182Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fabbaea80f7795008324786c63e60db88b8a5ae0ca832882248834eb6ca554da","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/zhongjin-capital"},{"id":"fabebceb-cbe4-49a8-839d-08f5ac0ff704","kind":"institutions","code":"UB-I8211","name":"苏州创景领航创业投资合伙企业（有限合伙）","nameBasis":"transliterated","summary":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","description":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","country":null,"category":null,"originalName":"苏州创景领航创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:22.102Z","englishUpdatedAt":"2026-10-16T01:39:38.828Z","reviewedAt":"2026-10-16T01:39:38.828Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"f61fcdff894085f0a7071248eba7b508779305b00dfe25528e5567c8a81eff76","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership)","path":"/institutions/suzhou-chuangjinglinghang-venture-capital-partnership-limited-partnership"}],"newsUrl":null,"evidence":{"headline":"Lingchuangyigu raises RMB 200 million in Series B+ financing","brief":"On 2026-06-18, according to Xiniu Data, Lingchuangyigu completed Series B+ financing, raising RMB 200 million. Investors were Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), Zhongjin Capital. The company is a developer of neuromodulation and brain-computer interface medical devices.","basis":"translated-source-brief","newsPath":"/news/72e2a0d3-024f-410d-b8bd-6a73f427e3b7","sourceCount":0}},{"id":"88dfa41f-2ea9-48e1-88fb-37bf6b462413","date":"2026-02-07T00:00:00.000Z","round":"Series B+","amountText":"金额未知","estimateUsd":null,"estimateLabel":"Undisclosed","estimateNote":null,"investors":"赛盈资本","institutions":[{"id":"b1bd9b1f-cf89-424f-87a8-67130db3f0f3","kind":"institutions","code":"UB-I5904","name":"赛盈资本","nameBasis":"transliterated","summary":"Saiying Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","description":"Saiying Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","country":null,"category":null,"originalName":"赛盈资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:21.716Z","englishUpdatedAt":"2026-10-15T21:21:01.761Z","reviewedAt":"2026-10-15T21:21:01.761Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3c88ffb5e63e684a25ab9ad63222e7a62274e6246539f05b52ed2f49ac7cd775","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Saiying Capital","path":"/institutions/saiying-capital"}],"newsUrl":null,"evidence":{"headline":"Lingchuangyigu completes Series B+ financing","brief":"On 2026-02-07, according to Xiniu Data, Lingchuangyigu completed Series B+ financing for an undisclosed amount. Investors were Saiying Capital.","basis":"translated-source-brief","newsPath":"/news/88dfa41f-2ea9-48e1-88fb-37bf6b462413","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":2,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":2,"records":[{"id":"72e2a0d3-024f-410d-b8bd-6a73f427e3b7","date":"2026-06-18T00:00:00.000Z","round":"Series B+","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"苏州创景领航创业投资合伙企业（有限合伙），中金资本","institutions":[{"id":"2b96e881-405d-416d-9147-cc33cf34c278","kind":"institutions","code":"UB-I127","name":"Zhongjin Capital","nameBasis":"transliterated","summary":"CICC's private investment and fund management platform, conducting equity investment and fund businesses.","description":"CICC's private investment and fund management platform, conducting equity investment and fund businesses.","country":null,"category":null,"originalName":"中金资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.826Z","englishUpdatedAt":"2026-10-15T21:25:20.182Z","reviewedAt":"2026-10-15T21:25:20.182Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fabbaea80f7795008324786c63e60db88b8a5ae0ca832882248834eb6ca554da","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/zhongjin-capital"},{"id":"fabebceb-cbe4-49a8-839d-08f5ac0ff704","kind":"institutions","code":"UB-I8211","name":"苏州创景领航创业投资合伙企业（有限合伙）","nameBasis":"transliterated","summary":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","description":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","country":null,"category":null,"originalName":"苏州创景领航创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:22.102Z","englishUpdatedAt":"2026-10-16T01:39:38.828Z","reviewedAt":"2026-10-16T01:39:38.828Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"f61fcdff894085f0a7071248eba7b508779305b00dfe25528e5567c8a81eff76","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership)","path":"/institutions/suzhou-chuangjinglinghang-venture-capital-partnership-limited-partnership"}],"newsUrl":null,"evidence":{"headline":"Lingchuangyigu raises RMB 200 million in Series B+ financing","brief":"On 2026-06-18, according to Xiniu Data, Lingchuangyigu completed Series B+ financing, raising RMB 200 million. Investors were Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), Zhongjin Capital. The company is a developer of neuromodulation and brain-computer interface medical devices.","basis":"translated-source-brief","newsPath":"/news/72e2a0d3-024f-410d-b8bd-6a73f427e3b7","sourceCount":0}},{"id":"88dfa41f-2ea9-48e1-88fb-37bf6b462413","date":"2026-02-07T00:00:00.000Z","round":"Series B+","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"赛盈资本","institutions":[{"id":"b1bd9b1f-cf89-424f-87a8-67130db3f0f3","kind":"institutions","code":"UB-I5904","name":"赛盈资本","nameBasis":"transliterated","summary":"Saiying Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","description":"Saiying Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","country":null,"category":null,"originalName":"赛盈资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:21.716Z","englishUpdatedAt":"2026-10-15T21:21:01.761Z","reviewedAt":"2026-10-15T21:21:01.761Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3c88ffb5e63e684a25ab9ad63222e7a62274e6246539f05b52ed2f49ac7cd775","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Saiying Capital","path":"/institutions/saiying-capital"}],"newsUrl":null,"evidence":{"headline":"Lingchuangyigu completes Series B+ financing","brief":"On 2026-02-07, according to Xiniu Data, Lingchuangyigu completed Series B+ financing for an undisclosed amount. Investors were Saiying Capital.","basis":"translated-source-brief","newsPath":"/news/88dfa41f-2ea9-48e1-88fb-37bf6b462413","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"72e2a0d3-024f-410d-b8bd-6a73f427e3b7","kind":"funding","eventDate":"2026-06-18T00:00:00.000Z","revenueDate":null,"round":"B+","amountText":"2亿人民币","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":28571428,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"苏州创景领航创业投资合伙企业（有限合伙），中金资本","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"2b96e881-405d-416d-9147-cc33cf34c278","kind":"institutions","code":"UB-I127","name":"Zhongjin Capital","nameBasis":"transliterated","summary":"CICC's private investment and fund management platform, conducting equity investment and fund businesses.","description":"CICC's private investment and fund management platform, conducting equity investment and fund businesses.","country":null,"category":null,"originalName":"中金资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.826Z","englishUpdatedAt":"2026-10-15T21:25:20.182Z","reviewedAt":"2026-10-15T21:25:20.182Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fabbaea80f7795008324786c63e60db88b8a5ae0ca832882248834eb6ca554da","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/zhongjin-capital"},{"id":"fabebceb-cbe4-49a8-839d-08f5ac0ff704","kind":"institutions","code":"UB-I8211","name":"苏州创景领航创业投资合伙企业（有限合伙）","nameBasis":"transliterated","summary":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","description":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","country":null,"category":null,"originalName":"苏州创景领航创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:22.102Z","englishUpdatedAt":"2026-10-16T01:39:38.828Z","reviewedAt":"2026-10-16T01:39:38.828Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"f61fcdff894085f0a7071248eba7b508779305b00dfe25528e5567c8a81eff76","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership)","path":"/institutions/suzhou-chuangjinglinghang-venture-capital-partnership-limited-partnership"}],"roundName":"Series B+","amountLabel":"RMB 200M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null},{"id":"88dfa41f-2ea9-48e1-88fb-37bf6b462413","kind":"funding","eventDate":"2026-02-07T00:00:00.000Z","revenueDate":null,"round":"B+","amountText":"金额未知","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":null,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"赛盈资本","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"b1bd9b1f-cf89-424f-87a8-67130db3f0f3","kind":"institutions","code":"UB-I5904","name":"赛盈资本","nameBasis":"transliterated","summary":"Saiying Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","description":"Saiying Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","country":null,"category":null,"originalName":"赛盈资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:21.716Z","englishUpdatedAt":"2026-10-15T21:21:01.761Z","reviewedAt":"2026-10-15T21:21:01.761Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3c88ffb5e63e684a25ab9ad63222e7a62274e6246539f05b52ed2f49ac7cd775","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Saiying Capital","path":"/institutions/saiying-capital"}],"roundName":"Series B+","amountLabel":"Undisclosed","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[{"id":"a7047b62-9c5d-48c4-8f2f-4174067bfddc","kind":"people","code":"UB-P2384","name":"Ding Shan","nameBasis":"transliterated","summary":"Co-founder and COO","description":"","country":null,"category":null,"originalName":"丁杉","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T20:00:16.146Z","englishUpdatedAt":"2026-10-15T18:37:42.248Z","reviewedAt":"2026-10-15T18:37:42.248Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"0c343bdc9f91189bce66be467fcab52f8adba40ec0be7c3e07458f86979cbb54","companyId":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","foundedYear":null,"logoUrl":null,"path":"/people/ding-shan"},{"id":"6983ae65-3a78-4bc1-bbfa-badb63fd8480","kind":"people","code":"UB-P2380","name":"Fan Bifa","nameBasis":"transliterated","summary":"Academic leader in pain medicine in China and professor.","description":"Academic leader in pain medicine in China and professor.","country":null,"category":null,"originalName":"樊碧发","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T20:00:16.118Z","englishUpdatedAt":"2026-10-15T19:39:49.573Z","reviewedAt":"2026-10-15T19:39:49.573Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"5e8699897e994dc370ec7ac5c975df49cf35ac1d95e3796462b6e6e49d307218","companyId":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","foundedYear":null,"logoUrl":null,"path":"/people/fan-bifa"},{"id":"4ceb7b59-489d-4e5e-bf34-a9f2dfcd0bc2","kind":"people","code":"UB-P2381","name":"Han Jisheng","nameBasis":"transliterated","summary":"Foundational figure in neuromodulation in China and an academician.","description":"Foundational figure in neuromodulation in China and an academician.","country":null,"category":null,"originalName":"韩济生","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T20:00:16.126Z","englishUpdatedAt":"2026-10-15T19:39:49.128Z","reviewedAt":"2026-10-15T19:39:49.128Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"a1b7c810173f5fd94750d948c4e5e216399f797fe97fa45d4cece0114ad1a6d0","companyId":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","foundedYear":null,"logoUrl":null,"path":"/people/han-jisheng"},{"id":"c8f6523a-e987-433c-a7ea-55ed1ffb1f65","kind":"people","code":"UB-P2378","name":"Xu Tianrui","nameBasis":"transliterated","summary":"Founder of Beijing Lingchuang Yigu Technology Development Co., Ltd., with more than a decade in neuromodulation and brain–computer interfaces. Starting with an innovative wireless implantable neural electrical stimulation platform, the company develops technologies for pain management and neuromodulation. It raised more than CNY 200 million in 2026.","description":"Founder of Beijing Lingchuang Yigu Technology Development Co., Ltd., with more than a decade in neuromodulation and brain–computer interfaces. Starting with an innovative wireless implantable neural electrical stimulation platform, the company develops technologies for pain management and neuromodulation. It raised more than CNY 200 million in 2026.","country":null,"category":null,"originalName":"徐天睿","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T20:00:16.107Z","englishUpdatedAt":"2026-10-15T23:20:32.984Z","reviewedAt":"2026-10-15T23:20:32.984Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"8515ae6a7a9075c059a130fa020161af767f709670f9f7379b48bc77630a2666","companyId":"b084bebe-a3dd-46d8-be62-1cbc624c24bf","foundedYear":null,"logoUrl":null,"path":"/people/xu-tianrui"}],"productsRelated":[],"investors":[{"id":"2b96e881-405d-416d-9147-cc33cf34c278","kind":"institutions","code":"UB-I127","name":"Zhongjin Capital","nameBasis":"transliterated","summary":"CICC's private investment and fund management platform, conducting equity investment and fund businesses.","description":"CICC's private investment and fund management platform, conducting equity investment and fund businesses.","country":null,"category":null,"originalName":"中金资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:54:24.826Z","englishUpdatedAt":"2026-10-15T21:25:20.182Z","reviewedAt":"2026-10-15T21:25:20.182Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"fabbaea80f7795008324786c63e60db88b8a5ae0ca832882248834eb6ca554da","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/zhongjin-capital"},{"id":"fabebceb-cbe4-49a8-839d-08f5ac0ff704","kind":"institutions","code":"UB-I8211","name":"苏州创景领航创业投资合伙企业（有限合伙）","nameBasis":"transliterated","summary":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","description":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership), an early-stage venture capital firm focused on healthcare.","country":null,"category":null,"originalName":"苏州创景领航创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:22.102Z","englishUpdatedAt":"2026-10-16T01:39:38.828Z","reviewedAt":"2026-10-16T01:39:38.828Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"f61fcdff894085f0a7071248eba7b508779305b00dfe25528e5567c8a81eff76","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Suzhou Chuangjinglinghang Venture Capital Partnership (Limited Partnership)","path":"/institutions/suzhou-chuangjinglinghang-venture-capital-partnership-limited-partnership"},{"id":"b1bd9b1f-cf89-424f-87a8-67130db3f0f3","kind":"institutions","code":"UB-I5904","name":"赛盈资本","nameBasis":"transliterated","summary":"Saiying Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","description":"Saiying Capital, a Chinese venture capital firm focused on the growth of startup-stage enterprises.","country":null,"category":null,"originalName":"赛盈资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:44:21.716Z","englishUpdatedAt":"2026-10-15T21:21:01.761Z","reviewedAt":"2026-10-15T21:21:01.761Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"3c88ffb5e63e684a25ab9ad63222e7a62274e6246539f05b52ed2f49ac7cd775","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Saiying Capital","path":"/institutions/saiying-capital"}],"path":"/companies/UB-C10168","structured":{"city":"Beijing","country":"China","location":null,"role":null,"category":null,"company":null},"definition":"Lingchuangyigu is a company headquartered in Beijing, China, founded in 2016.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/UB-C10168"}